Tenderwize
Back to tender search

Open house Arzneimittelrabattverträge Cinnarizin und Dimenhydrinat, ATC N07CA22

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Apr 05, 2027 · 232 days left·Open·Supplies·Framework
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Cinnarizin und Dimenhydrinat, ATC N07CA22

50/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

50 / 100

Complexity

20 / 100

Risk factors

The tender explicitly states it is not a public procurement but an open-house model. Legal remedies may be different (s...

No estimated value or volume disclosed; revenue potential is uncertain.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Supply of pharmaceutical products with active substances Cinnarizin and Dimenhydrinat (ATC N07CA22)
  • Non-exclusive discount agreements under SGB V §130a Abs. 8
Show full summary

This is an open-house model for non-exclusive discount agreements on pharmaceutical products Cinnarizin and Dimenhydrinat (ATC N07CA22) with AOK Bayern. It is not a competitive procurement; any qualified pharmaceutical company may enter into identical, non-negotiable discount agreements. The contract term runs from 01.06.2025 to 31.05.2027, with possible termination. Submission is either in paper form (two copies) or electronically with a qualified electronic signature. Eligibility is limited to pharmaceutical companies that submit a signed declaration of reliability. No estimated value, award criteria, or competitive selection is involved.

Risks

The tender explicitly states it is not a public procurement but an open-house model. Legal remedies may be different (s...

No estimated value or volume disclosed; revenue potential is uncertain.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Eligibility

  • Only pharmaceutical companies are eligible

Administrative

  • Must submit a signed declaration of reliability
  • Contract must be submitted in two paper copies or electronically with qualified electronic signature

Requirements may be incomplete.

Award Criteria

Lot 1

No award criteria; all qualified companies are accepted.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open house Arzneimittelrabattverträge Cinnarizin und Dimenhydrinat, ATC N07CA22

Non-exclusive discount agreements for pharmaceutical products containing the active substances Cinnarizin and Dimenhydrinat (ATC N07CA22). All qualified pharmaceutical companies may join.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

May 2025 - May 2027

Category

Pharmaceutical products

Award Criteria

No award criteria; all qualified companies are accepted.

Deadline

Deadline Apr 05, 2027

Procurement Details

Publication date
15 Apr 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
248752-2025

Documents (2)

Similar tenders